Use of risedronic acid or pharmaceutically acceptable salt thereof for the manufacture of a medicament for oral administration on one day per month for the prevention or the treatment of osteoporosis

摘要

The present invention refers to the use of bisphosphonic acids or pharmaceutically acceptable salts thereof for the manufacture of medicaments for the prevention or the treatment of disorders characterized by pathologically increased bone resorption, especially for the prevention and treatment of osteoporosis.